Prevalence of iron overload in pediatric oncology patients after blood transfusion

Clinical Advances in Hematology and Oncology

Volumn 10, Issue 6, 2012, Pages 363-365

  Gurram, Murali Krishna ^a   Newman, William ^a   Kobrinsky, Nathan ^a,b  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

^b MeritCare Roger Maris Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; C REACTIVE PROTEIN; CANCER PATIENT; CHILD; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTE TRANSFUSION;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; FERRITINS; HUMANS; IRON OVERLOAD; MALE; NEOPLASMS; PREVALENCE; YOUNG ADULT;

EID: 84864381162     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Milman N, Pedersen P, á Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol. 2001;80:737-744.
2. Bowen D, Culligan D, Jowitt S, et al. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol. 2003;120:187-200.
3. Jabbour E, Kantarjian HM, Koller C, Taher A. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes. Cancer. 2008;112:1089-1095.
4. Malcovati L. Impact of transfusion dependency and secondary iron over- load on the survival of patients with myelodysplastic syndromes. Leuk Res. 2007;31(suppl 3):S2-S6.
5. Lee JW, Kang HJ, Kim EK, Kim H, Shin HY, Ahn HS. Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children. Bone Marrow Trans. 2009;44:793-797.
6. Leitch HA. Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy. Leuk Res. 2007;31(suppl 3):S7-S9.
7. Pullarkat V, Blanchard S, Tegtmeier B, et al. Iron overload adversely affects out- come of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2008;42:799-805.
8. Hann HW, Lange B, Stahlhut MW, McGlynn KA. Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease. Cancer. 1990;66:313-316.
9. Brown K, Subramony C, May W, et al. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy. J Pediatr Hematol Oncol. 2009;31:309-312.
10. Bomford A, Williams R. Long term results of venesection therapy in idiopathic haemochromatosis. Q J Med. 1976;45:611-623.